<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7429937\results\search\disease\results.xml">
  <result pre="oxide in patients admitted to intensive care unit with COVID-19" exact="pneumonia" post="TavazziGuidoguido.tavazzi@unipv.it12MarcoPozzi2MongodiSilvia2DammassaValentino1RomitoGiovanni1MojoliFrancesco12[1], grid.8982.b0000 0004 1762 5736Department of Clinical-Surgical, Diagnostic and"/>
  <result pre="are characterised by poor oxygenation with a various extent of" exact="pulmonary" post="alterations [1]. Ventilation strategies for COVID-19 patients have been"/>
  <result pre="ventilated patients with refractory hypoxaemia and/or right ventricular (RV) dysfunction." exact="Refractory" post="hypoxaemia was defined as PaO2/FiO2â€‰ 2O) and prone position."/>
  <result pre="PaO2/FiO2â€‰ 2O) and prone position. RV dysfunction was defined as" exact="acute" post="cor pulmonale at echocardiography with hemodynamic impairment requiring infusion"/>
  <result pre="2O) and prone position. RV dysfunction was defined as acute" exact="cor pulmonale" post="at echocardiography with hemodynamic impairment requiring infusion of inotropic"/>
  <result pre="was introduced into the inspiratory limb of the ventilator tubing." exact="Respiratory" post="and haemodynamic parameters were collected immediately before iNO administration"/>
  <result pre="had also superimposed RV dysfunction, in 1 case associated with" exact="pulmonary embolism." post="The iNO dosage was 25 [20â€&quot;30] parts per million"/>
  <result pre="The iNO dosage was 25 [20â€&quot;30] parts per million (ppm)." exact="Respiratory" post="parameters at t0 and t1 are shown in TableÂ"/>
  <result pre="not change (pâ€‰=â€‰0.875) 24â€‰h later (146.4 [102.2â€&quot;225.1]). Table 1 Patients" exact="respiratory" post="and hemodynamic parameters at the two time points Parameter"/>
  <result pre="95%] SBP systolic blood pressure, MAP mean arterial pressure, HR" exact="heart" post="rate, bpm beats per minutes, MetHb methemoglobin, PEEP positive"/>
  <result pre="that diffuses across the alveolar-capillary membrane into the subjacent smooth" exact="muscle" post="of pulmonary vessels enhancing endothelium-dependent vasorelaxation and improving oxygenation"/>
  <result pre="across the alveolar-capillary membrane into the subjacent smooth muscle of" exact="pulmonary" post="vessels enhancing endothelium-dependent vasorelaxation and improving oxygenation by increasing"/>
  <result pre="improving PaO2/FiO2 and oxygenation index, although it failed in reversing" exact="acute" post="lung injury, reducing mechanical ventilation days and mortality [4]."/>
  <result pre="is yet to be determined, some speculation can be done." exact="Severe" post="endothelial injury with cytoplasmic vacuolization and cell detachment in"/>
  <result pre="Severe endothelial injury with cytoplasmic vacuolization and cell detachment in" exact="pulmonary" post="middle-small arteries can make the pulmonary vessels less reactive"/>
  <result pre="and cell detachment in pulmonary middle-small arteries can make the" exact="pulmonary" post="vessels less reactive to iNO stimulation [1, 5, 6]."/>
  <result pre="loss of hypoxic vasoconstriction and lung perfusion regulation. However, whether" exact="vascular" post="derangements in COVID-19 are due to endothelial cell involvement"/>
  <result pre="disclose. References References 1.Marini JJ, Gattinoni L. Management of COVID-19" exact="respiratory" post="distress. JAMA. 2020. Online ahead of print. 2.NarendraDKHessDRSesslerCNBeleteHMGuntupalliKKKhusidFCarpatiCMAstizMERaoofSUpdate in"/>
  <result pre="Online ahead of print. 2.NarendraDKHessDRSesslerCNBeleteHMGuntupalliKKKhusidFCarpatiCMAstizMERaoofSUpdate in management of severe hypoxemic" exact="respiratory" post="failureChest201715286787910.1016/j.chest.2017.06.03928716645 3.IchinoseFRobertsJDJrZapolWMInhaled nitric oxide: a selective pulmonary vasodilator: current"/>
  <result pre="of severe hypoxemic respiratory failureChest201715286787910.1016/j.chest.2017.06.03928716645 3.IchinoseFRobertsJDJrZapolWMInhaled nitric oxide: a selective" exact="pulmonary" post="vasodilator: current uses and therapeutic potentialCirculation20041093106311110.1161/01.CIR.0000134595.80170.6215226227 4.Gebistorf F, Karam"/>
  <result pre="Karam O, Wetterslev J, Afshari A. Inhaled nitric oxide for" exact="acute" post="respiratory distress syndrome (ARDS) in children and adults. Cochrane"/>
  <result pre="O, Wetterslev J, Afshari A. Inhaled nitric oxide for acute" exact="respiratory" post="distress syndrome (ARDS) in children and adults. Cochrane Database"/>
  <result pre="J, Afshari A. Inhaled nitric oxide for acute respiratory distress" exact="syndrome" post="(ARDS) in children and adults. Cochrane Database Syst Rev."/>
  <result pre="Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell" exact="infection" post="and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417â€&quot;8."/>
 </snippets>
</snippetsTree>
